FDA Proposes Mandatory GRAS Reporting, but Courts May Block It

On August 10, 2026, the FDA proposed requiring manufacturers to notify the agency of all ingredients marketed under GRAS — meaning ingredients deemed "generally recognized as safe" without formal approval. The rule would apply retroactively and going forward, creating the first complete GRAS inventory. A 2021 federal ruling upheld only voluntary notification, signaling likely legal challenges ahead.